Pirfenidone Alleviates Against Fine Particulate Matter-Induced Pulmonary Fibrosis Modulating via TGF-β1/TAK1/MKK3/p38 MAPK Signaling Pathway in Rats

Pirfenidone Alleviates Against Fine Particulate Matter-Induced Pulmonary Fibrosis Modulating via TGF-β1/TAK1/MKK3/p38 MAPK Signaling Pathway in Rats

Increased exposure to particulate matter (PM) from air pollution causes lung inflammation and increases morbidity and mortality due to respiratory diseases. Pirfenidone is an anti-fibrotic agent used to treat idiopathic pulmonary fibrosis. <b>Background/Objectives</b>: In this experiment...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jun-Seok Sung, Il-Gyu Ko, Lakkyong Hwang, Sang-Hoon Kim, Jin Hee Han, Jung Won Jeon, Sae Rom Kim, Jeong Mi Lee, Cheon Woong Choi
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Biomedicines
Subjects:	particulate matter pirfenidone pulmonary fibrosis inflammation bronchoalveolar lavage fluid
Online Access:	https://www.mdpi.com/2227-9059/13/4/989
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bronchoalveolar Lavage Derived Fibroblasts From Interstitial Lung Disease Patients: A Chance to Exploit 2D/3D Model of Pulmonary Fibrosis In Vitro
by: Paolo Giannoni, et al.
Published: (2025-07-01)

Pediatric Interventional Flexible Bronchoscopy
by: Wen-Jue Soong
Published: (2018-07-01)

Can Pirfenidone and Nintedanib Be Alternative Treatment Options for Radiation Pneumonitis?
by: Hikmet COBAN, et al.
Published: (2025-06-01)

The pulmoprotective effects of pirfenidone against paraquat-induced pulmonary toxicity: a systematic review
by: Sajjad Sadeghi, et al.
Published: (2025-06-01)

Flexible Bronchoscopy in Children: The Marmara University Division of Pediatric Pulmonology Experience
by: Almala Pınar Ergenekon, et al.
Published: (2022-09-01)

Therapeutic Whole Lung Lavage for Pulmonary Alveolar Proteinosis: Technique With Continuous Video‐Enabled Double Lumen Endotracheal Tube
by: Kevin Davidson
Published: (2025-03-01)

Pirfenidone combined with UC-MSCs reversed bleomycin-induced pulmonary fibrosis
by: Jingran Xu, et al.
Published: (2025-08-01)

Acneiform drug eruption from pirfenidone
by: Jordyn Puccio, BS, et al.
Published: (2025-07-01)

Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life Study
by: Olcay Aycicek, et al.
Published: (2025-02-01)

Features of the cytogram and cytokine profile of bronchoalveolar lavage fluid in experimental metabolic syndrome
by: O. V. Voronkova, et al.
Published: (2023-01-01)

Clinical, cytologic, bacteriologic and radiographic analysis of respiratory diseases in dogs
by: Mehmet Maden, et al.

Pneumocystis jirovecii colonization in bronchoalveolar lavage among naïve non-small cell lung cancer from tertiary respiratory hospital in Jakarta, Indonesia
by: Jamal Zaini, et al.
Published: (2022-10-01)

Diagnostic value of bronchoalveolar lavage in children with nonresponding community-acquired pneumonia
by: Chih-Min Tsai, et al.
Published: (2017-10-01)

Evaluating the Efficacy of a Polymerase Chain Reaction Assay for Pneumocystis carinii Detection in Respiratory Samples
by: Sonu Kumari Agarwal, et al.
Published: (2024-12-01)

Location of Bronchoalveolar Lavage in Children
by: Natcha Sakrajai, et al.
Published: (2019-01-01)

The updated evidence of pirfenidone treated silicosis based on network pharmacology, molecular docking and experimental validation
by: Sirong Chang, et al.
Published: (2025-05-01)

Whole Lung Lavage in Autoimmune Pulmonary Alveolar Proteinosis: Unique Challenges in a Resource‐Limited Setting
by: Ashesh Dhungana, et al.
Published: (2024-11-01)

The unexplored mechanism of antitumoral effect of pirfenidone in melanoma cells
by: Melissa Marchese, et al.
Published: (2025-08-01)

Assessment of the alveolar clearance: a critical review
by: V. I. Kobylyansky
Published: (2023-06-01)

Microbiosthma: a prospective study following respiratory microbiota in young children with severe preschool wheezing to better understand their respiratory future
by: Hortense Petat, et al.
Published: (2025-07-01)

Non Tubercular Mycobacterial Infection as a Cause of Non Resolving Aspiration Pneumonia in a Case of Achalasia Cardia: A Case Report
by: Shailesh Bhanudas Meshram, et al.
Published: (2024-11-01)

Cigarette smoking and acute eosinophilic pneumonia: insights from a case series of 17 patients
by: I Re Heo, et al.
Published: (2025-03-01)

Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone
by: Tomohiko Yagi, et al.
Published: (2025-02-01)

Pirfenidone reduces ovarian fibrosis and improves PCOS in letrozole-induced rat model
by: Ayşe Çakır Gündoğdu, et al.
Published: (2025-06-01)

Distribution of two CD4+FOXP3+ T cell subpopulations reflects disease phenotypes and prognosis in COPD
by: Jia Hou, et al.
Published: (2025-05-01)

MACROPHAGE AND CYTOKINE PROFILES OF BRONCHOALVEOLAR LAVAGE IN NEW AND RELAPSING RESPIRATORY SARCOIDOSIS
by: N. G. Demyanenko, et al.
Published: (2016-09-01)

Local and systemic cytokine profiles in children with pneumonia-associated lung consolidation
by: Jilei Lin, et al.
Published: (2025-05-01)

Cases of Lungworm in Cats from Southern Poland in the Autopsy and Cytological Material
by: Stanisław Dzimira, et al.
Published: (2025-06-01)

An on-farm observational study on the prevalence and associated factors of bacteremia in preweaned dairy calves diagnosed with bronchopneumonia by thoracic ultrasonography
by: Antonio Boccardo, et al.
Published: (2025-04-01)

Analysis of the Correlation between Immune Cell Subsets in Bronchoalveolar Lavage Fluid and the Efficacy of First-line Use of Immunotherapy in Advanced Non-small Cell Lung Cancer: A Case-control Study
by: Kai ZHANG, et al.
Published: (2024-12-01)

SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY
by: Ivan GUR, et al.
Published: (2024-01-01)

Factors associated with Mycoplasma pneumoniae-induced Lobar pneumonia with mucus plugging and the optimal timing for bronchoalveolar lavage: a retrospective study
by: Guotao Zou, et al.
Published: (2025-04-01)

Distinct Molecular Profiles Underpin Mild-To-Moderate Equine Asthma Cytological Profiles
by: Anna E. Karagianni, et al.
Published: (2024-11-01)

Performance of Xpert MTB/RIF and acid-fast bacilli smear microscopy for the diagnosis of pulmonary tuberculosis using bronchoalveolar lavage samples in negative or sputum-scarce adults in Colombia: a retrospective diagnostic accuracy study
by: Vanessa Sabella-Jiménez, et al.
Published: (2025-04-01)

Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients
by: Simón A. Ojeda-Duran, et al.
Published: (2020-05-01)

High tidal volume mechanical ventilation exacerbates pulmonary injury via upregulation of PAI-1 expression in rats
by: Jun-ming Ren, et al.
Published: (2025-07-01)

Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient RegistryTake-home Points
by: Mohleen Kang, MD, MS, et al.
Published: (2024-12-01)

The predictive value of MUC5AC levels in the sputum of children with Mycoplasma pneumoniae pneumonia treated with fiberbronchoscopy
by: Xiao-qing Jian, et al.
Published: (2025-08-01)

Biomarker-Driven Pharmacokinetics and Efficacy of Polymyxin B in Critically Ill Patients with XDR-GN Pneumonia
by: Wei Zuo, et al.
Published: (2025-04-01)

Aspects of Stage-by-Stage Diagnosis of Pulmonary Mycobacteriosis in Real Clinical Practice
by: N. L. Karpina, et al.
Published: (2023-04-01)